Liminal BioSciences Inc. (LMNL)

NASDAQ: LMNL · IEX Real-Time Price · USD
0.430
0.00 (0.00%)
Oct 5, 2022 12:00 AM EDT - Market open

Income Statement (Annual)

Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Year 202120202019201820172016
Revenue
0.640.720.7524.6322.3116.39
Revenue Growth (YoY)
-11.19%-2.82%-96.98%10.40%36.12%-
Cost of Revenue
00025.713.697.63
Gross Profit
0.640.720.75-1.0718.628.76
Selling, General & Admin
31.9332.6237.6629.4529.5628.47
Research & Development
18.3514.2315.8784.8693.5287.62
Other Operating Expenses
0.341.090.76149.9520.490.84
Operating Expenses
50.6247.9454.3264.26143.58116.92
Operating Income
-49.97-47.22-53.55-265.33-124.95-108.16
Interest Expense / Income
6.332.96.8722.047.894.53
Other Expense / Income
-67.9769.68147.612.6911.8-5.25
Pretax Income
11.66-119.8-208.02-300.06-144.64-107.45
Income Tax
0.12-0.21-0.23-19.64-14.3-6.64
Net Income
11.54-119.59-207.8-280.43-130.34-100.81
Net Income Common
11.54-119.59-207.8-280.43-130.34-100.81
Shares Outstanding (Basic)
302416111
Shares Outstanding (Diluted)
302416111
Shares Change
23.43%52.15%1839.86%4.02%33.02%-
EPS (Basic)
0.43-4.83-12.81-235.95-137.85-0.17
EPS (Diluted)
0.43-4.83-12.81-235.95-137.85-0.17
Free Cash Flow Per Share
-3.32-3.19-6.46-105.78-166.65-189.22
Gross Margin
100.00%100.00%100.00%-4.40%83.50%53.40%
Operating Margin
-7771.90%-6521.50%-7188.20%-1077.10%-560.00%-659.90%
Profit Margin
1795.30%-16517.80%-27892.20%-1138.40%-584.10%-615.00%
Free Cash Flow Margin
-15554.30%-10750.00%-13937.40%-355.50%-594.50%-690.70%
Effective Tax Rate
1.01%0.17%0.11%6.54%9.89%6.18%
EBITDA
22.34-108.45-191.25-272.56-132.18-99.67
EBITDA Margin
3473.70%-14979.60%-25671.00%-1106.50%-592.40%-608.00%
Depreciation & Amortization
4.348.459.915.464.583.25
EBIT
17.99-116.9-201.16-278.02-136.75-102.92
EBIT Margin
2798.10%-16146.30%-27000.70%-1128.70%-612.90%-627.90%
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).